“Study of Levofloxacin and Cefoperazone-Sulbactam Utilization Cost on Patients With Mild and Moderate Corona Virus Disease- 2019: Studi Biaya Penggunaan Antibiotik Levofloxacin Dan Cefoperazone-Sulbactam Pada Pasien Corona Virus Disease-2019 Derajat Ringan Sampai Sedang”. Journal Pharmasci (Journal of Pharmacy and Science), vol. 9, no. 1, June 2024, pp. 59-63, https://doi.org/10.53342/pharmasci.v9i1.316.